MEK Inhibition Remodels the Immune Landscape of Mutant <i>KRAS</i> Tumors to Overcome Resistance to PARP and Immune Checkpoint Inhibitors

Bin Yang(Hubei Cancer Hospital), Gang Chen(Tongji Hospital)
Cancer Research
February 15, 2021
Cited by 53


Related Papers